Clinical Trial Update: A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liposomal irinotecan (Onivyde) in combination with 5-FU/leucovorin and bevacizumab for advanced colorectal cancer. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil with leucovorin (5-fluorouracil with leucovorin)
• Bevacizumab (bevacizumab)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: Sanjun Cai | Conditions: Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING